Cleared Traditional

K071384 - MODIFICATION TO: DIGITAL BLOOD PRESSURE MONITOR, MODEL 1901

K071384 is an FDA 510(k) clearance for MODIFICATION TO: DIGITAL BLOOD PRESSURE..., manufactured by Nihon Seimitsu Sokki Co., Ltd.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 145-day FDA review.

K071384 · Nihon Seimitsu Sokki Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2007
Decision
145d
Days
Class 2
Risk

K071384 is an FDA 510(k) clearance for the MODIFICATION TO: DIGITAL BLOOD PRESSURE MONITOR, MODEL 1901. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Nihon Seimitsu Sokki Co., Ltd. (Tachikawa-Shi, Tokyo, JP). The FDA issued a Cleared decision on October 9, 2007 after a review of 145 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K071384

510(k) Number K071384 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 17, 2007
Decision Date October 09, 2007
Days to Decision 145 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d slower than avg
Panel avg: 125d · This submission: 145d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 1213
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K071384.
CONTINUOUS NON-INVASIVE CARDIAC OUTPUT AND BLOOD PRESSURE MONITOR WITH REAL-TIME HEMODYNAMICS
K072049 · Bmeye B.V. · Nov 2007
MOBIL-O-GRAPH NG 24 H ABP-CONTROL
K072446 · I.E.M. GmbH · Nov 2007
A-PLUS ARTERIAL PULSE WAVEFORM ANALYSIS SYSTEM AND PC SOFTWARE
K072593 · Healthstats International Pte. , Ltd. · Nov 2007
HONEYWELL HOMMED CENTRAL STATION 4.0
K072272 · Honeywell Hommed, LLC · Sep 2007
KD-795 WRIST MEASUREMENT ELECTRONIC BLOOD PRESSURE MONITOR
K070826 · Kodon(Tianjin)Electronic&Electrical Apparatus Co., · Aug 2007
KD-595 FULLY AUTOMATIC ELECTRONIC BLOOD PRESSURE MONITOR
K070828 · Kodon(Tianjin)Electronic&Electrical Apparatus Co., · Aug 2007
K071384 · MODIFICATION TO: DIGITAL BLOOD PRESSURE MONITOR, MODEL 1901
Download PDF FDA Summary Nihon Seimitsu Sokki …